We are live on
!
Find out more
AIM
Arcadia Investment Management Portfolio holdings
AUM
$584M
1-Year Est. Return
21.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.34%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$499M
AUM Growth
+$15.2M
(+3.1%)
Cap. Flow
+$1.59M
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
30.86%
Holding
289
New
39
Increased
56
Reduced
66
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.21M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.02M |
| 3 |
WisdomTree International Quality Dividend Growth Fund
IQDG
|
+$1.59M |
| 4 |
Chegg
CHGG
|
+$1.55M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$2.65M |
| 2 |
Fortive
FTV
|
+$2.09M |
| 3 |
Apple
AAPL
|
+$1.04M |
| 4 |
Broadcom
AVGO
|
+$1.03M |
| 5 |
Texas Pacific Land
TPL
|
+$896K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.76% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Industrials | 9.04% |
| 5 | Financials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Banco Santander
SAN
$210B
| $1K | ﹤0.01% |
+293
| New | +$993 |
|
277
Western Union
WU
$2.2B
| $1K | ﹤0.01% |
25
+1
| +4% | +$24 |
|
|
MTEM
278
DELISTED
Molecular Templates, Inc.
MTEM
| $1K | ﹤0.01% |
6
| – | – |
|
|
CDK
279
DELISTED
CDK Global, Inc.
CDK
| $1K | ﹤0.01% |
22
| – | – |
|
|
ACB
280
Aurora Cannabis
ACB
$216M
| $0 | ﹤0.01% |
4
| – | – |
|
281
AstraZeneca
AZN
$247B
| – | – |
-800
| Closed | -$80K |
|
282
DexCom
DXCM
$33.7B
| $0 | ﹤0.01% |
+4
| New | +$375 |
|
283
Five Below
FIVE
$13.1B
| – | – |
-428
| Closed | -$75K |
|
284
FMC
FMC
$1.3B
| – | – |
-503
| Closed | -$58K |
|
|
GRMN
285
Garmin
GRMN
$59.7B
| – | – |
-2,000
| Closed | -$239K |
|
286
Kontoor Brands
KTB
$4.16B
| $0 | ﹤0.01% |
3
-15
| -83% | -$670 |
|
287
Methanex
MEOH
$4.2B
| – | – |
-250
| Closed | -$12K |
|
288
Newmont
NEM
$123B
| – | – |
-1,000
| Closed | -$60K |
|
|
VIVO
289
DELISTED
Meridian Bioscience Inc
VIVO
| – | – |
-1,000
| Closed | -$19K |
|
Similar funds
CGIM
TAM
GIM
IIA
TCM
FMI
PFG
JCP
Arcadia Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, Arcadia Investment Management held 289 positions worth $499M, up 3.1% from $484M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Arcadia Investment Management's Q1 2021 filing shows 39 new, 56 increased, 66 reduced and 7 closed positions. Its largest new stake was WisdomTree International Quality Dividend Growth Fund: 42,362 shares worth $1.57M. The largest sale was Stryker, an estimated $2.65M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Arcadia Investment Management's largest Q1 2021 buy was WisdomTree International Quality Dividend Growth Fund: 42,362 shares worth $1.57M.
- Arcadia Investment Management added most to Vanguard Short-Term Bond ETF in Q1 2021, an estimated $3.21M increase.
- Arcadia Investment Management's biggest Q1 2021 reduction was Stryker, cutting an estimated $2.65M.
- Arcadia Investment Management fully exited Garmin in Q1 2021, selling an estimated $239K.
- Arcadia Investment Management's ten largest holdings make up 31% of its $499M portfolio in Q1 2021.
- Arcadia Investment Management opened 39 new positions and closed 7 in Q1 2021.
- Arcadia Investment Management's portfolio value rose 3.1% quarter-over-quarter to $499M.
Based on Arcadia Investment Management's 13F filing for Q1 2021, filed 30 Apr 2021.